Jane M. Johnston

Dr. Johnston became Vice President of Operations at Neurotez in 2011. Prior to this, she was Executive Director of Research at Neurotez since the company’s incorporation in 2005. Dr. Johnston is regarded as an expert in neural repair and cellular imaging. She has more than 18 years of research experience in cellular neuroscience and handling human tissues. Her research contributed to the discovery of leptin as a potential therapy for Alzheimer’s disease and to the identification of NT1 and NT2 for Familial Alzheimer’s Disease – current Neurotez pipeline products. Her recent work at Neurotez includes the development of high throughput screening assays and lab certification for bioanalysis.

Dr. Johnston graduated with a Ph.D. in biochemistry from Imperial College of Science, Technology, and Medicine, University of London and was a Visiting Fellow at the National Institutes of Neurological Disorders and Stroke, at the NIH, Bethesda Maryland. She has held a number of research positions including principal investigator at the University of Medicine and Dentistry of New Jersey, the Albert Einstein College of Medicine, New York, and she has consulted for Johnson & Johnson. In addition, Dr. Johnston has taught undergraduate and graduate courses in biomedical sciences and authored numerous scientific publications.